BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34628071)

  • 21. Therapies for Olfactory Dysfunction - an Update.
    Jafari A; Holbrook EH
    Curr Allergy Asthma Rep; 2022 Mar; 22(3):21-28. PubMed ID: 35072929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view.
    Huart C; Philpott CM; Altundag A; Fjaeldstad AW; Frasnelli J; Gane S; Hsieh JW; Holbrook EH; Konstantinidis I; Landis BN; Macchi A; Mueller CA; Negoias S; Pinto JM; Poletti SC; Ramakrishnan VR; Rombaux P; Vodicka J; Welge-Lüessen A; Whitcroft KL; Hummel T
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1041-1046. PubMed ID: 33728824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.
    Jensen MM; Larsen KD; Homøe AS; Simonsen AL; Arndal E; Koch A; Samuelsen GB; Nielsen XC; Todsen T; Homøe P
    PLoS One; 2022; 17(10):e0275518. PubMed ID: 36191024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In response to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Bakhshaee M
    Laryngoscope; 2023 Apr; 133(4):E31. PubMed ID: 36495295
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study.
    Denis F; Septans AL; Periers L; Maillard JM; Legoff F; Gurden H; Moriniere S
    J Med Internet Res; 2021 May; 23(5):e29583. PubMed ID: 34003765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A primer on viral-associated olfactory loss in the era of COVID-19.
    Soler ZM; Patel ZM; Turner JH; Holbrook EH
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):814-820. PubMed ID: 32271490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients.
    Abdelazim MH; Abdelazim AH; Ismaiel WF; Alsobky ME; Younes A; Hadeya AM; Ramzy S; Shahin M
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4623-4628. PubMed ID: 35567630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory Dysfunction in the COVID-19 Outbreak.
    Izquierdo-Dominguez A; Rojas-Lechuga MJ; Mullol J; Alobid I
    J Investig Allergol Clin Immunol; 2020; 30(5):317-326. PubMed ID: 32406374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
    Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM
    Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.
    Prajapati DP; Shahrvini B; Said M; Srinivas S; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2021 Nov; 11(11):1529-1537. PubMed ID: 34096193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From pathophysiology to therapeutic management of loss of smell in Covid-19].
    Nguyen DT; Masson V; Jankowski R; Toussaint B; Gallet P; Rumeau C; Chenuel B
    Rev Prat; 2021 Jan; 71(1):13-19. PubMed ID: 34160932
    [No Abstract]   [Full Text] [Related]  

  • 35. The study of olfactory dysfunction in SARS-CoV-2 variants.
    Vaira LA; Boscolo-Rizzo P; Bui Quoc E; Bandekela P; Saussez S; Lechien JR
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5469-5470. PubMed ID: 35841408
    [No Abstract]   [Full Text] [Related]  

  • 36. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.
    Lechien JR; Chiesa-Estomba CM; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):464-465. PubMed ID: 33527593
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases.
    Vasconcelos CCF; Hammerle MB; Sales DS; Rueda Lopes FC; Pinheiro PG; Gouvea EG; Alves MCDF; Pereira TV; Schmidt SL; Alvarenga RMP; Pires KL
    J Neurovirol; 2022 Apr; 28(2):312-318. PubMed ID: 35366736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70.
    Kitchen LC; Berman M; Halper J; Chazot P
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.
    Hirano K; Tanaka Y; Kamimura S; Suzaki I; Suzuki E; Kobayashi H
    Am J Case Rep; 2022 Sep; 23():e936496. PubMed ID: 36089753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.